-
1 Comment
InMode Ltd is currently in a long term uptrend where the price is trading 43.4% above its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.5.
InMode Ltd's total revenue rose by 60.0% to $75M since the same quarter in the previous year.
Its net income has increased by 89.7% to $36M since the same quarter in the previous year.
Finally, its free cash flow grew by 52.5% to $42M since the same quarter in the previous year.
Based on the above factors, InMode Ltd gets an overall score of 5/5.
ISIN | IL0011595993 |
---|---|
Exchange | NASDAQ |
CurrencyCode | USD |
Industry | Medical Devices |
Sector | Healthcare |
Dividend Yield | 0.0% |
---|---|
PE Ratio | 19.22 |
Target Price | 46.6 |
Market Cap | 3B |
Beta | 2.11 |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for INMD using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024